Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Lipid mediators are crucial for the pathogenesis of rheumatoid arthritis (RA); however, global analyses have not been undertaken to systematically define the lipidome underlying the dynamics of disease evolution, activation, and resolution. Here, we performed untargeted lipidomics analysis of synovial fluid and serum from RA patients at different disease activities and clinical phases (preclinical phase to active phase to sustained remission). We found that the lipidome profile in RA joint fluid was severely perturbed and that this correlated with the extent of inflammation and severity of synovitis on ultrasonography. The serum lipidome profile of active RA, albeit less prominent than the synovial lipidome, was also distinguishable from that of RA in the sustained remission phase and from that of noninflammatory osteoarthritis. Of note, the serum lipidome profile at the preclinical phase of RA closely mimicked that of active RA. Specifically, alterations in a set of lysophosphatidylcholine, phosphatidylcholine, ether-linked phosphatidylethanolamine, and sphingomyelin subclasses correlated with RA activity, reflecting treatment responses to anti-rheumatic drugs when monitored serially. Collectively, these results suggest that analysis of lipidome profiles is useful for identifying biomarker candidates that predict the evolution of preclinical to definitive RA and could facilitate the assessment of disease activity and treatment outcomes.
Abstract
Lipid mediators are crucial for the pathogenesis of rheumatoid arthritis (RA); however, global analyses have not been undertaken to systematically define the lipidome underlying the dynamics of disease evolution, activation, and resolution. Here, we performed untargeted lipidomics analysis of synovial fluid and serum from RA patients at different disease activities and clinical phases (preclinical phase to active phase to sustained remission). We found that the lipidome profile in RA joint fluid was severely perturbed and that this correlated with the extent of inflammation and severity of synovitis on ultrasonography. The serum lipidome profile of active RA, albeit less prominent than the synovial lipidome, was also distinguishable from that of RA in the sustained remission phase and from that of noninflammatory osteoarthritis. Of note, the serum lipidome profile at the preclinical phase of RA closely mimicked that of active RA. Specifically, alterations in a set of lysophosphatidylcholine, phosphatidylcholine, ether-linked phosphatidylethanolamine, and sphingomyelin subclasses correlated with RA activity, reflecting treatment responses to anti-rheumatic drugs when monitored serially. Collectively, these results suggest that analysis of lipidome profiles is useful for identifying biomarker candidates that predict the evolution of preclinical to definitive RA and could facilitate the assessment of disease activity and treatment outcomes.
참고문헌 (51)
- Schoels, M., "Evidence for treating rheumatoid arthritis to target : Results of a systematic literature search", Ann. Rheum. Dis, 69, pp.638~643 (2010)
- Smolen, J. S., "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2019 update", Ann. Rheum. Dis, 79, pp.685~699 (2020)
- Ajeganova, S., "Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis : an increasingly achievable outcome with subsidence of disease symptoms", Ann. Rheum. Dis, 75, pp.867~873 (2016)
- Mankia, K., "Preclinical rheumatoid arthritis : Progress toward prevention", Arthritis Rheumatol, 68, pp.779~788 (2016)
- Nielen, M. M. J., "Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors", Arthritis Rheum, 50, pp.380~386 (2004)
- Aletaha, D., "2010 rheumatoid arthritis classification criteria : An American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2010, pp.62, 2569~2581
- Rantapää-Dahlqvist, S., "Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis", Arthritis Rheum, 48, pp.2741~2749 (2003)
- Ramos-Remus, C., "Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease", Arthritis Rheumatol, 67, pp.2837~2844 (2015)
- Smolen, J. S., "Treating rheumatoid arthritis to target : 2014 update of the recommendations of an international task force", Ann. Rheum. Dis, 75, pp.3~15 (2016)
- van Gestel, A. M., "Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization", International League Against Rheumatism Criteria, 1996, pp.39, 34~40
- Wolfe, F., "The clinical and research significance of the erythrocyte sedimentation rate", J. Rheumatol, 21, pp.1227~1237 (1994)
- Pincus, T., "Optimisation of assessment for rheumatic diseases in clinical trials, observational studies, and routine clinical care", Clin. Exp. Rheumatol, 32, pp.S–1~ (2014)
- Han, X., "Lipidomics for studying metabolism", Nat. Rev. Endocrinol, 12, pp.668~679 (2016)
- Wymann, M. P., "Lipid signalling in disease", Nat. Rev. Mol. Cell Biol, 9, pp.162~176 (2008)
- Rodriguez-Carrio, J., "Profiling of serum oxylipins during the earliest stages of rheumatoid arthritis", Arthritis Rheumatol, 73, pp.401~413 (2021)
- Polinski, K. J., "Association of lipid mediators with development of future incident inflammatory arthritis in an anti-citrullinated protein antibody-positive population", Arthritis Rheumatol, 73, pp.955~962 (2021)
- Han, X., "Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics", J. Lipid Res, 44, pp.1071~1079 (2003)
- Szkudlarek, M., "Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis", Arthritis Rheum, 48, pp.955~962 (2003)
- D’Agostino, M. -A., "Scoring ultrasound synovitis in rheumatoid arthritis : a EULAR-OMERACT ultrasound taskforce—Part 1 : Definition and development of a standardised, consensus-based scoring system", RMD Open, 3, pp.e000428~ (2017)
- Matyash, V., "Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics", J. Lipid Res, 49, pp.1137~1146 (2008)
- Yoon, S. J., "Comprehensive multi-omics analysis reveals aberrant metabolism of Epstein-Barr-Virus-associated gastric carcinoma", Cells, 8, pp.1220~ (2019)
- Tsugawa, H., "MS-DIAL: Data-independent MS", MS deconvolution for comprehensive metabolome analysis, 2015, pp.12, 523~526
- Fan, S., "Systematic error removal using random forest for normalizing largescale untargeted lipidomics data", Anal. Chem, 91, pp.3590~3596 (2019)
- Wagner, F., "GO-PCA : An unsupervised method to explore gene expression data using prior knowledge", PLoS One, 10, pp.e0143196~ (2015)
- Molenaar, M. R., "LION", web: A web-based ontology enrichment tool for lipidomic data analysis, 2019, pp.8, giz061~
- Xia, J., "MetaboAnalyst : A web server for metabolomic data analysis and interpretation", Nucleic Acids Res, 37, pp.W652~W660 (2009)
- Just, S. A., "Six-month prospective trial in early and long-standing rheumatoid arthritis : Evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAROMERACT ultrasound score", RMD Open, 5, pp.e000951~ (2019)
- Alivernini, S., "Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission?", Ann. Rheum. Dis, 76, pp.1228~1236 (2017)
- Chen, L. S., "A regularized Hotelling’s T(2)test for pathway analysis in proteomic studies", J. Am. Stat. Assoc, 106, pp.1345~1360 (2011)
- Korotkova, M., "Persisting eicosanoid pathways in rheumatic diseases", Nat. Rev. Rheumatol, 10, pp.229~241 (2014)
- Gan, R. W., "Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study", Rheumatology, 55, pp.367~376 (2016)
- Chu, S. H., "Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses’ Health Study", Rheumatology, 59, pp.3369~3379 (2020)
- Kay, J., "Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: Acute phase reactant levels contribute separately to predicting outcome at one year", Arthritis Res. Ther, 16, pp.R40~ (2014)
- Sokka, T., "Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%–45% of patients with rheumatoid arthritis seen between 1980 and 2004 : Analyses from Finland and the United States", J. Rheumatol, 36, pp.1387~1390 (2009)
- Prevoo, M. L., "Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis", Arthritis Rheum, 38, pp.44~48 (1995)
- Chiurchiu, V., "Bioactive lipids and chronic inflammation : Managing the fire within", Front. Immunol, 9, pp.38~ (2018)
- Cas, M. D., "Functional lipids in autoimmune inflammatory diseases", Int. J. Mol. Sci, 21, pp.3074~ (2020)
- Chiurchiù, V., "Bioactive lipids as modulators of immunity, inflammation, and emotions", Curr. Opin. Pharmacol, 29, pp.54~62 (2016)
- Law, S. -H., "An updated review of lysophosphatidylcholine metabolism in human diseases", Int. J. Mol. Sci, 20, pp.1149~ (2019)
- Graham, A., "Factors regulating the secretion of lysophosphatidylcholine by rat hepatocytes compared with the synthesis and secretion of phosphatidylcholine and triacylglycerol. Effects of albumin, cycloheximide, verapamil, EGTA, and chlorpromazine", Biochem. J, 253, pp.687~692 (1988)
- Lourida, E. S., "Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2", Arthritis Res. Ther, 9, pp.R19~ (2007)
- Sonkar, K., "Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer", NMR Biomed, 32, pp.e4112~ (2019)
- Leidl, K., "Mass spectrometric analysis of lipid species of human circulating blood cells", Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1781, pp.655~664 (2008)
- Huang, L. S., "Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory", Lipids, 45, pp.225~236 (2010)
- Myasoedova, E., "Lipid paradox in rheumatoid arthritis : The impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease", Ann. Rheum. Dis, 70, pp.482~487 (2011)
- Stegemann, C., "Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study", Circulation, 129, pp.1821~1831 (2014)
- 이영기, "Lysophosphatidylcholine, Oxidized Low-Density Lipoprotein and Cardiovascular Disease in Korean Hemodialysis Patients: Analysis at 5 Years of Follow-up", Journal of Korean Medical Science, 28(2), pp.268~273 (2013), 대한의학회
- Aviña-Zubieta, J. A., "Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies", Arthritis Rheum, 59, pp.1690~1697 (2008)
- Guma, M., "Choline kinase inhibition in rheumatoid arthritis", Ann. Rheum. Dis, 74, pp.1399~1407 (2015)
- Rangholia, N., "Bioactive ether lipids : Primordial modulators of cellular signaling", Metabolites, 11, pp.41~ (2021)
- Dean, J. M., "Structural and functional roles of ether lipids", Protein Cell, 9, pp.196~206 (2018)